← 전체 보충제 목록

페퍼민트 오일 (IBS)

Peppermint Oil (IBS)

📑 PubMed 13편 🫄 소화

📚 관련 논문 (13편)

1.
Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases or irritable bowel syndrome: A systematic literature review and meta-analysis.
Nutrition & dietetics : the journal of the Dietitians Association of Australia 2022 PMID:33960587

1. Nutr Diet. 2022 Feb;79(1):76-93. doi: 10.1111/1747-0080.12672. Epub 2021 May 7. Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases or irritable bowel syndrome: A systematic literature review and meta-analysis. Giang J(1), Lan X(1), Crich

2.
Therapy options in irritable bowel syndrome.
European journal of gastroenterology & hepatology 2010 PMID:21389791

2. Eur J Gastroenterol Hepatol. 2010 Dec;22(12):1402-11. doi: 10.1097/MEG.0b013e3283405a17. Therapy options in irritable bowel syndrome. Enck P(1), Junne F, Klosterhalfen S, Zipfel S, Martens U. Author information: (1)Department of Internal Medicine VI, University Hospital, Tübingen, Germany. p

3.
A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome.
United European gastroenterology journal 2021 PMID:34468079

3. United European Gastroenterol J. 2021 Nov;9(9):997-1006. doi: 10.1002/ueg2.12134. Epub 2021 Sep 1. A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome. Weerts ZZRM(1), Essers BAB(2), Jonkers DMAE(1), Willems JIA(1), Janssen DJPA(1), Witteman BJM(

4.
Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial.
The American journal of gastroenterology 2021 PMID:34319275

4. Am J Gastroenterol. 2021 Nov 1;116(11):2279-2285. doi: 10.14309/ajg.0000000000001395. Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial. Nee J(1), Ballou S(1), Kelley JM(2)(3), Kaptchuk TJ(2), Hirsch W(1), Katon J(1), Cheng V(1), Rangan V(1), Lembo

5.
Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical Trials.
Nutrition reviews 2025 PMID:39110917

5. Nutr Rev. 2025 Mar 1;83(3):e1343-e1354. doi: 10.1093/nutrit/nuae107. Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical Trials. Zeraattalab-Motlagh S(1), Ranjbar M(2), Mohammadi H(2), Adi

6.
Menthacarin, a Proprietary Peppermint Oil and Caraway Oil Combination, Improves Multiple Complaints in Patients with Functional Gastrointestinal Disorders: A Systematic Review and Meta-Analysis.
Digestive diseases (Basel, Switzerland) 2023 PMID:36502789

6. Dig Dis. 2023;41(3):522-532. doi: 10.1159/000528553. Epub 2022 Dec 9. Menthacarin, a Proprietary Peppermint Oil and Caraway Oil Combination, Improves Multiple Complaints in Patients with Functional Gastrointestinal Disorders: A Systematic Review and Meta-Analysis. Madisch A(1), Frieling T(2),

7.
Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.
Alimentary pharmacology & therapeutics 2022 PMID:35942669

7. Aliment Pharmacol Ther. 2022 Sep;56(6):932-941. doi: 10.1111/apt.17179. Epub 2022 Aug 9. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. Ingrosso MR(1)(2), Ianiro G(1)(2), Nee J(3), Lembo AJ(3), Moayyedi P(4), Black CJ(5)(6), Ford AC(5)(6). Autho

8.
Effects of gastrointestinal delivery of non-caloric tastants on energy intake: a systematic review and meta-analysis.
European journal of nutrition 2021 PMID:33559026

8. Eur J Nutr. 2021 Sep;60(6):2923-2947. doi: 10.1007/s00394-021-02485-4. Epub 2021 Feb 8. Effects of gastrointestinal delivery of non-caloric tastants on energy intake: a systematic review and meta-analysis. Klaassen T(1)(2), Keszthelyi D(3), Troost FJ(3)(4), Bast A(4), Masclee AAM(3). Author

9.
Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Complementary therapies in medicine 2020 PMID:31987249

9. Complement Ther Med. 2020 Jan;48:102233. doi: 10.1016/j.ctim.2019.102233. Epub 2019 Nov 3. Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis. Hawrelak JA(1), Wohlmuth H(2), Pattinson M(3), Myers SP(4), Goldenberg JZ(5), Harnett J(6),

10.
Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
The lancet. Gastroenterology & hepatology 2020 PMID:31859183

10. Lancet Gastroenterol Hepatol. 2020 Feb;5(2):117-131. doi: 10.1016/S2468-1253(19)30324-3. Epub 2019 Dec 16. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. Black CJ(1), Yuan Y(2), Selinge

11.
The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data.
BMC complementary and alternative medicine 2019 PMID:30654773

11. BMC Complement Altern Med. 2019 Jan 17;19(1):21. doi: 10.1186/s12906-018-2409-0. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. Alammar N(1)(2), Wang L(3), Saberi B(4), Nanavati J(1), Holtmann G(5), Shinohara RT(6), Mullin GE(7). A

12.
Effectiveness of Menthacarin on symptoms of irritable bowel syndrome.
Wiener medizinische Wochenschrift (1946) 2019 PMID:29728848

12. Wien Med Wochenschr. 2019 Apr;169(5-6):149-155. doi: 10.1007/s10354-018-0635-1. Epub 2018 May 4. Effectiveness of Menthacarin on symptoms of irritable bowel syndrome. Madisch A(1), Miehlke S(2), Labenz J(3), Stracke B(4), Köhler S(4). Author information: (1)Medical Department I, Academic Tea

13.
WITHDRAWN: Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood.
The Cochrane database of systematic reviews 2014 PMID:24532249

13. Cochrane Database Syst Rev. 2014 Feb 17;2014(2):CD003017. doi: 10.1002/14651858.CD003017.pub3. WITHDRAWN: Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Huertas-Ceballos AA(1), Logan S, Bennett C, Macarthur C, Martin AE. Aut

⚠️ 면책 고지

이 정보는 일반 교육 목적이며 의료 진단/처방을 대체하지 않습니다.